# Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer

> **NCT05352737** · — · COMPLETED · sponsor: **KU Leuven** · enrollment: 300 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** methylmalonic acid testing

## Key facts

- **NCT ID:** NCT05352737
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-22
- **Primary completion:** 2022-06-24
- **Final completion:** 2022-06-24
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05352737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05352737, "Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05352737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*